DNA adduct level in lung tissue may act as a risk biomarker of lung cancer

European Journal of Cancer

Volumn 36, Issue 11, 2000, Pages 1381-1388

  Cheng, Y W ^a   Chen, C Y ^b   Lin, P ^e   Chen, C P ^a   Huang, K H ^a   Lin, T S ^c   Wu, M H ^d   Lee, H ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NONE

Author keywords

Aromatic hydrophobic DNA adducts; Lung cancer

Indexed keywords

ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; TUMOR MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; ENZYME POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DNA ADDUCTS; DNA DAMAGE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 0033920855     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00131-3     Document Type: Article

References (41)

1. Ger L.P., Lious S.H., Shen C.Y. Risk factors of lung cancer. J. Formosa. Med. Assoc. 91:1992;S222-S231.
2. Annual Report of Tobacco. Alcohol Consumption Investigation in Taiwan Area. Taipei, Taiwan, Bureau of Tobacco and Alcohol Monopoly. Taiwan Provincial Government, 1993.
3. Travis W.D., Lubin J., Ries L., Devesa S. United States lung carcinoma incidence trends. Am. Cancer Soc. 77:1996;2464-2470.
4. Lubin J.H., Blot W.J., Berrino F.et al. Patterns of lung cancer risk according to type of cigarette smoked. Int. J. Cancer. 33:1984;569-576.
5. Lewtas J., Walsh R., Williams R., Dobias L. Air pollution exposure-DNA adduct dosimetry in humans and rodents. evidence for non-linearity at high doses Mutat. Res. 378:1997;51-63.
6. Phillips D.H., Hewer A., Martin C.N., Garner R.C., King M.M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature. 336:1988;790-792.
7. 32P-postlablling assay. Carcinogenesis. 12:1991;503-508.
8. Phillips D.H., Schoket B., Hewer A., Bailey E., Kostic S., Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer. 46:1990;569-575.
9. Ryberg D., Kure E., Lystad S.et al. p53 mutation in lung tumors. relatonship to putative susceptibility markers for cancer Cancer Res. 54:1994;1551-1555.
10. Poirier M.C. DNA adducts as exposure biomarkers and indicator of cancer risk. Environ. Health Perspect. 105:1997;907-912.
11. Kriek E., Rojas M., Alexandrov K., Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans. relevance as biomarkers for exposure and cancer risk Mutat. Res. 400:1998;215-231.
12. La D.K., Swenberg J.A. DNA adducts. biological markers of exposure and potential application to risk assessment Mutat. Res. 365:1996;129-146.
13. Perrera F. Molecular epidemiology. insights into cancer susceptibility, risk assessment, and prevention J. Natl. Cancer Inst. 88:1996;496-509.
14. Bartsch H., Hietanen E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect. 104:1996;569-577.
15. Warren A.J., Shields P. Molecular epidemiology. carcinogen-DNA adducts and genetic susceptibility Mol. Epidemiol. 216:1997;172-180.
16. Ichiba M., Hagmar L., Rannug A.et al. Aromatic DNA adducts, micronuclei and gentic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis. 15:1994;1347-1352.
17. Shields P.G., Bowman E.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
18. 32P analysis of cigarette smoking-induced DNA damage in human tissues and mouse skin. Cancer Res. 46:1986;5869-5877.
19. 32P-postlabeling analysis of aromatic carcinogen. DNA adducts Cancer Res. 45:1985;5656-5662.
20. Chen C.C., Lee H. Geneotoxicity of DNA adduct formation of incense smoke condensates. comparison with cigarette smoke condensate Mutat. Res. 367:1996;105-114.
21. Hayashi S., Watanable J., Nakachi K., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem. 10:1991;407-411.
22. Groppi A., Couttele C., Fleury B., Iron A., Beugeret J., Couzigous P. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum. Genet. 87:1991;628-630.
23. Schoket B., Phillip D.H., Kostic S., Vincze I. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis. 19:1998;841-846.
24. Dunn B.P., Vedal S., San R.H.C.et al. DNA adducts in bronchial biopsies. Int. J. Cancer. 48:1991;485-492.
25. Rannug A., Alexandrie A.K., Persson I., Ingelman-Sundberg M. Genetic polymorphism of cytochromes P4501A1, 2D6, and 2E1. regulation and toxicological significance J. Occup. Environ. Med. 37:1995;25-36.
26. Bartsch H., Rojas M., Alexandrov K.et al. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in human. Pharmacogenetics. 5:1995;S84-S90.
27. Tang D., Santella R.M., Blackwood A.M.et al. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomarker Prev. 4:1995;341-346.
28. Schwartz D., Almog N., Peled A., Goldfinger N., Rotter V. Role of wild type p53 in the G2 phase. regulation of the γ-irradiation-induced delay and DNA repair Oncogene. 15:1997;2597-2607.
29. Lewtas J., Walsh D., Williams R., Dobias L. Air pollution exposure-DNA adduct dosimetry in human and rodents. evidence for non-linearity at high doses Mutat. Res. 378:1997;51-63.
30. 32P-Postlabeling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers. saturation at high exposures Mutat. Res. 378:1997;65-75.
31. Lee H., Su S.Y., Liu K.S., Chou M.C. Correlation between meteorological conditions and mutagenicity of airborne particulate samples in a tropical monsoon climate area from Kaohsiung city, Taiwan. Environ. Mol. Mutagen. 23:1994;200-207.
32. Kuo C.Y., Cheng Y.W., Chen C.Y., Lee H. Correlation between the amounts of polycyclic aromatic hydrocarbons and mutagenicity of airborne particulate samples from Taichung city, Taiwan. Environ. Res. 78:1998;43-49.
33. Nakachi K., Imai K., Hayashi S., Kawajirio K. Polymorphisms of the CYP1A1 and Glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53:1993;2994-2999.
34. Garcia-Closas M., Kelsey K.T., Wiencke J.K., Xu X., Wain J.C., Christiani D.C. A case-control study of cytochrome P4501A1 glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility. Cancer Cause Control. 8:1997;544-553.
35. Lin P., Wang S.L., Wang H.J.et al. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br. J. Cancer. 82:2000;857-859.
36. Kato S., Bowman E.D., Harrington A.M., Blomeke B., Shields P.G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87:1995;902-907.
37. Ryberg D., Skaug V., Hewer A.et al. Genotype of glutathione S-transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
38. To-Figueras J., Gene M., Gomez-Catalan J.et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis. 18:1997;1529-1533.
39. Alexandrov K., Rojas M., Geneste O.et al. An improved fluorometric assay for dosimetry of benezo(a)pyrene diol-epoxide-DNA adducts in smokers' lung. comparision with total bulky adducts and aryl hydrocarbon hydroxylase activity Cancer Res. 52:1992;6248-6253.
40. Hussain S.P., Harris C.C. Molecular epidemiology of human cancer. contribution of mutation spectra studies of tumor suppressor genes Cancer Res. 58:1998;4023-4037.
41. Otteneder M., Lutz W.K. Correlation of DNA adduct levels with tumor incidence. carcinogenic potency of DNA adducts Mutat. Res. 424:1999;237-247.